C12Y 605/01002
Dna ligase
Official title: DNA ligase (NAD+) (6.5.1.2)
C12Y605/01002 (Dna ligase) appears on 8 US grants and 13 published applications in this corpus.
Search patents in C12Y- Granted patents
- 8
- Published applications
- 13
- Assignees
- 8
- Inventors
- 29
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 2 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 2 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Fragmentation of DNA26 May 2026US 12,637,712 B2New England Biolabs, Inc.
- Fragmentation of DNA6 Jun 2023US 11,667,968 B2New England Biolabs, Inc.
- Multiple ligase compositions, systems, and methods21 Sep 2021US 11,124,789 B2Rgene, Inc.
- Multiple ligase compositions, systems, and methods21 Apr 2020US 10,626,390 B2Rgene, Inc.
- Modified nucleotides methods and kits7 Jan 2020US 10,526,652 B2Pierce Biotechnology, Inc.
- Fully genetically encoded nad+protein probe based on resonance energy transfer,and preparation method therefor and use thereof17 Sep 2026US 2026/0275323 A1Shenzhen Institutes of Advanced Technology
- Fragmentation of DNA20 Aug 2026US 2026/0242865 A1New England Biolabs, Inc.
- Use of fana antisense oligonucleotides for the prevention and management of huanglongbing and zebra chip diseases23 Jan 2025US 2025/0027079 A1
- Material and method for preparation of small, single-stranded dna circles18 Jul 2024US 2024/0240216 A1Purdue Research Foundation
- Fragmentation of DNA17 Aug 2023US 2023/0257808 A1New England Biolabs, Inc.
Most cited
By later US patents